# US 2026/0027072 A1 · Compositions to modulate the gut microbiota and to manage weight

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0027072 A1
- Document ID: US20260027072A1
- Status: Published application
- Kind: A1
- Application number: 19/247,394
- Filed: 2025-06-24
- Published: 2026-01-29
- Earliest claimed: 2015-06-01
- Assignees: Lpoxy Therapeutics, Inc.
- Applicants: LPOXY Therapeutics, Inc.
- Inventors: Hasan Celiker
- Web page: https://patentgrep.com/patent/US20260027072A1

## CPC

- A61K 31/17: having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine (isoureas, isothioureas A61K31/155; sulfonylureas A61K31/64)
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 9/2846: {Poly(meth)acrylates}
- A61K 9/2866: {Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose}
- A61K 9/4866: {Organic macromolecular compounds}
- A61K 9/4891: {Coated capsules; Multilayered drug free capsule shells (with drug coating for immediate release A61K9/4808; osmotic devices A61K9/0004)}
- A61K 31/185: Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids (hydroxamic acids A61K31/16; peroxy acids A61K31/327)
- A61K 31/327: Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 33/40: Peroxides
- A61K 38/44: Oxidoreductases (1)
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 3/04: Anorexiants; Antiobesity agents
- C12Y 111/01006: Catalase (1.11.1.6)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12Y: ENZYMES

## Abstract

Methods of weight management for a subject are provided. Generally the methods comprising: administering an effective amount to the small intestine and/or large intestine of the subject of at least one agent that increases oxygen tension and/or redox potential and/or pH in the colon of the subject to thereby manage the weight of the subject. Also provided are compositions comprising at least one agent that increases oxygen tension and/or redox potential and/or pH, wherein the composition is formulated for delivery of an effective amount of the at least one agent to the small intestine and/or large intestine of a subject following oral administration of the composition to the subject.

## Claims

### Claim at position 1

-31. (canceled)

### Claim 32

A composition comprising at least one agent that increases oxygen tension and/or redox potential and/or pH, wherein the composition is formulated for delivery of an effective amount of the at least one agent to the small intestine and/or large intestine of a subject following oral administration of the composition to the subject.

### Claim 33 (depends on 32)

The composition of claim 32, wherein oral administration of the composition to the subject increases oxygen tension and/or redox potential and/or pH in the colon of the subject.

### Claim 34 (depends on 32)

The composition of claim 32, wherein the at least one agent increases oxygen tension and is a peroxide.

### Claim 35 (depends on 32)

The composition of claim 32, wherein the at least one agent increases pH and is selected from bicarbonate salts, carbonate salts, bases, and buffers.

### Claim 36 (depends on 32)

The composition of claim 32, wherein the at least one agent is a peroxide catalyst.

### Claim 37 (depends on 32)

The composition of claim 32, wherein the at least one agent is selected from carbamide peroxide, sodium percarbonate, sodium bicarbonate, and catalase.

### Claim 38 (depends on 32)

The composition of claim 32, wherein the composition comprises at least one of carbamide peroxide and sodium percarbonate, and further comprises catalase.

### Claim 39 (depends on 38)

The composition of claim 38, wherein the composition further comprises sodium bicarbonate.

### Claim 40 (depends on 32)

The composition of claim 32, wherein the composition is formulated as an oral dosage form comprising the at least one agent and an enteric coating encasing the at least one agent.

### Claim 41 (depends on 40)

The composition of claim 40, wherein the oral dosage form is formulated for sustained release.

### Claim at position 12

-49. (canceled)

### Claim 50

A composition comprising at least 10 mg, at least 25 mg, at least 50 mg, at least 75 mg, or at least 100 mg of at least one peroxide selected from carbamide peroxide and sodium percarbonate;
wherein the composition is formulated for oral administration;
wherein the composition is formulated with enteric coating; and
wherein the composition is formulated for sustained release.

### Claim 51 (depends on 50)

The composition of claim 50, wherein the composition comprises at least 100 mg of carbamide peroxide.

### Claim 52 (depends on 50)

The composition of claim 50, wherein the composition comprises at least 100 mg of sodium percarbonate.

### Claim 53

A composition comprising at least 10 mg, at least 25 mg, at least 50 mg, at least 75 mg, or at least 100 mg of catalase;
wherein the composition is formulated for oral administration;
wherein the composition is formulated with enteric coating; and
wherein the composition is formulated for sustained release.

### Claim 54 (depends on 53)

The composition of claim 53, wherein the composition comprises at least 100 mg of catalase.

### Claim at position 18

-58. (canceled)
